COMMUNIQUÉS West-GlobeNewswire

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
26/06/2024
FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
26/06/2024
SAN FRANCISCO, June 26, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment [...]
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
26/06/2024
MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as [...]
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
26/06/2024
CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company, today announced that it has regained compliance [...]
Progyny, Inc. to Host 2024 Inaugural Investor Day
26/06/2024
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day [...]
Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities
26/06/2024
This new registration statement does not relate to any previously undisclosed new issuances of dilutive securities. Includes issuance of shares underlying warrants originally issued in 2021, earnout shares previously [...]
SMISS Asia Pacific 2024 Congress and training program
26/06/2024
Press release Ecully, June 26, 2024 – 6 p.m. Hands-on surgical training in Hong Kong at the SMISS Asia Pacific 2024 Congress The Spineway Group, a specialist in innovative implants for the treatment of severe spine [...]
Congrès Asie Pacifique SMISS 2024 et programme de formation
26/06/2024
Communiqué de presse Ecully, le 26 juin 2024 – 18h Formations pratiques chirurgicales à Hong Kong lors du congrès SMISS Asia Pacific 2024 Le groupe Spineway spécialiste des implants innovants pour le traitement des [...]
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board
26/06/2024
Saint-Herblain (France), June 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale et la nomination d’un nouvel administrateur à son conseil d’administration
26/06/2024
Saint-Herblain (France), le 26 juin 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’ [...]
EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1
26/06/2024
Press Release Agreement with Sanofi on a 200 M€ investment through a Perpetual Subordinated Hybrid Bond, upon the completion of the ongoing discussions to amend and extend the current Revolving Credit Facility 75 to 80 [...]
EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’une future croissance rentable1
26/06/2024
Communiqué de presse Accord avec Sanofi pour un investissement de 200 millions d’euros via une obligation Hybride Subordonnée à Durée Indéterminée, à l'issue des discussions en cours destinées à amender et à étendre le [...]
Allergy Named Highest-Impact Journal in Allergy and Clinical Immunology for 2024
26/06/2024
ZURICH, Switzerland, June 26, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) is thrilled to announce that Allergy , one of EAACI’s official journals, has been recognised as the [...]
CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
26/06/2024
HOUSTON, June 26, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointed Treasurer and Director, Mr [...]
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss
26/06/2024
Bagsværd, Denmark, 26 June 2024 – Novo Nordisk today announced that the CLARION-CKD phase 3 trial failed to meet its primary endpoint and that it will recognise an impairment loss of around DKK 5.7 billion related to [...]
COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
26/06/2024
Former Horizon Therapeutics CEO adds valuable expertise in the discovery, development, and commercialization of treatments for autoimmune and inflammatory diseases CHICAGO, June 26, 2024 (GLOBE NEWSWIRE) -- COUR [...]
Safety Shot Partners with Atlantic Beverage Distributors to Expand Distribution Into Massachusetts and Rhode Island
26/06/2024
This Partnership Marks the Next Step in the Company’s Expansion Plan in the Northeast JUPITER, FL, June 26, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc . (Nasdaq: SHOT) (the “Company), announced today its strategic [...]
Positron Corporation Orders 5 NeuSight PET-CT Scanners for US Market
26/06/2024
Niagara Falls, NY, June 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
26/06/2024
Lengthens Patent Exclusivity of Plogosertib until August 2040 BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]

Pages